Mechanism of action is a major differentiator
While the difference was not dramatic (~3 points, which is well below the minimally clinically important difference in the MDS-UPDRS-3 of around ~5 points), it appeared to remain after a 2-month washout period, intended to support the idea that, because the improvements remained after removal of the incretin, the difference should be a disease-modifying, rather than a symptomatic benefit
I have two boxes of Ozempic left
Long-term structural outcomes, including cartilage preservation and delayed joint replacement risk, still require further study
Through therapy, Jelly Roll learned to interrupt binge-eating patterns in real time , stepping away from trigger environments and questioning the emotional story driving the urge to eat